NPS PHARMACEUTICALS INC 4
4 · NPS PHARMACEUTICALS INC · Filed Feb 14, 2014
Insider Transaction Report
Form 4
GRONINGER JAMES G
Director
Transactions
- Exercise/Conversion
Common Stock
2014-02-13+15,188→ 15,938 total - Sale
Common Stock
2014-02-13$37.70/sh−6,000$226,200→ 9,938 total - Award
Restricted Stock Units
2014-02-12+4,572→ 4,572 total→ Common Stock (4,572 underlying) - Exercise/Conversion
Restricted Stock Units
2014-02-13−15,188→ 0 totalExercise: $0.00→ Common Stock (15,188 underlying)
Footnotes (5)
- [F1]Each vested Restricted Stock Unit was the economic equivalent of one share of common stock of NPS Pharmaceuticals, Inc. (the "Issuer"). The vested Restricted Stock Units were settled for shares of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2013.
- [F3]Each Restricted Stock Unit was awarded under the Issuer's amended and restated 2005 Omnibus Incentive Plan and represents a contingent right to receive one share of the Issuer's common stock.
- [F4]One hundred percent of the Restricted Stock Units will vest on the first anniversary of the date of grant. Vested shares will be delivered to the Reporting Person as soon as administratively practicable following the vesting of the Restricted Stock Units.
- [F5]On February 13, 2013, the Restricted Stock Units were granted with one hundred percent of such Restricted Stock Units vesting on the first anniversary of the date of grant. As of the date of this filing, all of the Restricted Stock Units have vested.